MENUNews Archive
Date: 09/16/2020
A new $3.7 million grant, as part of the Beau Biden Cancer Moonshot Initiative, will support a clinical trial designed to test a personalized family genetic risk navigation support platform. The trial will be extended to all first- and second-degree relatives of 900 patients in Georgia and California in whom genetic testing identified a variant indicating an elevated hereditary cancer risk.
Date: 09/15/2020
A team of researchers from the Rogel Cancer Center have received a $2.9 million grant from the National Cancer Institute to look at how HPV behaves in patients with head and neck cancer and how that could help identify who might benefit from less-aggressive treatment.
Date: 09/09/2020
If cancer is a series of puzzles, a new study pieces together how several of those puzzles connect to form a bigger picture.
One major piece is the immune system and the question of why certain immune cells stop doing their job. Another piece involves how histones are altered within immune cells. A third piece is how a cell’s metabolism processes amino acids.
Date: 08/28/2020
Using a technique called single-cell RNA sequencing, a research team from U-M was able to show for the first time how individual cells within a single population of cancer cells respond differently to the DNA damage caused by chemotherapy.
Date: 08/26/2020
What is the connection between COVID-19 and cancer? Arul Chinnaiyan, M.D., Ph.D., has focused his entire career on cancer, identifying in 2005 a protein that plays a key role in the development of prostate cancer. It turns out it may also factor into how coronaviruses replicate.
Date: 08/24/2020
Rogel Cancer Center members have received grant funding for 10 projects related to COVID-19. Some are using their basic science acumen or public health perspective to better understand the virus and its implications. Others focus on the coronavirus’s impact on the care of people with cancer.
Date: 08/17/2020
Researchers at the University of Michigan have discovered a new potential treatment approach for DIPG. One that significantly lengthened survival times in two mouse models.
Date: 08/07/2020
Research led by the Rogel Cancer Center is trying a new approach: Make radiation therapy more effective for glioblastoma patients by targeting a critical metabolic pathway and disrupting its ability to repair the DNA damage caused by the radiation.
Date: 07/28/2020
The Rogel Cancer Center continued to be among the nation’s best cancer programs and the only one in Michigan to be rated.
Date: 07/22/2020
New data on outcomes of people with cancer diagnosed with COVID-19 show a racial disparity in access to Remdesivir, an antiviral drug that shortens hospital stays, and increases mortality associated with dexamethasone.